Why the study?
Does a Genomic Risk Score (GRS) based on a large number of SNPs improve coronary heart disease risk prediction compared to traditional clinical risk scores?
Does a Genomic Risk Score (GRS) based on a large number of SNPs improve coronary heart disease risk prediction compared to traditional clinical risk scores?
A genomic risk score utilizing numerous SNPs enhances coronary heart disease risk prediction beyond traditional clinical risk scores.
Answers are grounded in this paper and cite their sources.
May refine CHD risk stratification beyond clinical scores; leaves open prospective validation of clinical impact.
A GRS based on a large number of SNPs improves CHD risk prediction and encodes different trajectories of lifetime risk not captured by traditional clinical risk scores.
No takes yet. Share an insight, caveat, or question.
Abraham et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: